BC

Bhushan Chaturvedi

Active Director Director DIN 10738527
DIN 10738527 First appointment Aug 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhushan Chaturvedi

Data last updated:

Bhushan Chaturvedi is a Director at Sterozide Pharma Private Limited (since 2024).

DIN 10738527
Primary Designation Director
First Appointment 10 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sterozide Pharma Private Limited U32503UP2024PTC207706
Director10 Aug 20242024Active

Board colleagues of Bhushan Chaturvedi

NameDINCompanyDesignation
Mohd Zahaib10738528Sterozide Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sterozide Pharma Private Limited
Premium access

Shareholding and investment profile for Bhushan Chaturvedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhushan Chaturvedi

Bhushan Chaturvedi currently holds 1 directorship: Sterozide Pharma Private Limited (Director, since 10 Aug 2024).

Bhushan Chaturvedi was first appointed on 10 Aug 2024 as Director at Sterozide Pharma Private Limited.

The current boards of Bhushan Chaturvedi's companies include Mohd Zahaib (Sterozide Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available